Activation of the Wnt pathway in non small cell lung cancer: Evidence of dishevelled overexpression

Oncogene

Volumn 22, Issue 46, 2003, Pages 7218-7221

  Uematsu, Kazutsugu ^a,b   He, Biao ^a   You, Liang ^a   Xu, Zhidong ^a   McCormick, Frank ^a   Jablons, David Mark ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dishevelled (Dvl); Non small cell lung cancer; siRNA; Wnt signaling

Indexed keywords

DISHEVELLED PROTEIN; DVL 1 PROTEIN; DVL 2 PROTEIN; DVL 3 PROTEIN; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CELL GROWTH; CLINICAL ARTICLE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; TUMOR STEM CELL ASSAY; WNT PROTEINS; ZEBRAFISH PROTEINS;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0242551656     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206817     Document Type: Article

References (18)

1. Brantjes H, Barker N, van Es J and Clevers H. (2002). Biol. Chem., 383, 255-261.
2. Brognard J and Dennis PA. (2002). Cell Death Differ., 9, 893-904.
3. Cagatay T and Ozturk M. (2002). Oncogene, 21, 7971-7980.
4. Hommura F, Furuuchi K, Yamazaki K, Ogura S, Kinoshita I, Shimizu M, Moriuchi T, Katoh H, Nishimura M and Dosaka-Akita H. (2002). Cancer, 94, 752-758.
5. Li L, Mao J, Sun L, Liu W and Wu D. (2002). J. Biol. Chem., 277, 5977-5981.
6. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, White RL and Matsunami N. (2001). Mol. Cell, 7, 927-936.
7. Matsuzawa SI and Reed JC. (2001). Mol. Cell, 7, 915-926.
8. Minna JD. (1998). Harrison's Principles of Internal Medicine, Vol. 14. Fauci AS, Braunwald E, Isselbacher KJ, Martin JB (eds). McGraw-Hill: New York, pp. 522-562.
9. Morin PJ. (1999). BioEssays, 21, 1021-1030.
10. Polakis P. (2000). Genes Dev., 14, 1837-1851.
11. Sekido Y, Fong KM and Minna JD. (1998). Biochim. Biophys. Acta, 1378, F21-F59.
12. Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM and Kitajewski J. (1997). Cell Growth Differ., 8, 1349-1358.
13. Sunaga N, Kohno T, Kolligs FT, Fearon ER, Saito R and Yokota J. (2001). Genes Chromosom. Cancer, 30, 316-321.
14. Ueda M, Gemmill RM, West J, Winn R, Sugita M, Tanaka N, Ueki M and Drabkin HA. (2001). Br. J. Cancer, 85, 64-68.
15. Wang J, Shou J and Chen X. (2000). Oncogene, 19, 1843-1848.
16. Wharton Jr KA. (2003). Dev. Biol., 253, 1-17.
17. Winn RA, Bremnes RM, Bemis L, Franklin WA, Miller YE, Cool C and Heasley LE. (2002). Oncogene, 21, 7497-7506.
18. You L, Uematsu K, McBrine MJ, McCormick F and Jablons DM. (2001). Proc. Am. Assoc. Cancer Res., 42, 609.